Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
Journal article
Wang T. et al, (2021), BMC Infectious Diseases, 21
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure.
Journal article
Smith DA. et al, (2021), Nature communications, 12
Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT
Journal article
Cooke GS. et al, (2021), Efficacy and Mechanism Evaluation, 8, 1 - 90
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019.
Journal article
Wang T. et al, (2021), Hepatol Commun, 5, 1586 - 1604
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Journal article
Cooke G. et al, (2021)
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy
Journal article
Smith DA. et al, (2021), Journal of Viral Hepatitis
Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID‐19 patients as prognostic markers
Journal article
Wang T. et al, (2021), Hepatology Communications
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Journal article
Cooke GS. et al, (2021), Wellcome Open Research, 6, 93 - 93
Efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) monoinfection: longitudinal analysis of a UK cohort
Journal article
Wang T. et al, (2020)
National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis research.
Journal article
Smith DA. et al, (2020), BMJ health & care informatics, 27
Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance Analysis for HCV Patients with Prior Failure to DAAs
Journal article
Smith DA. et al, (2020)
Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub-Saharan Africa and South East Asia
Journal article
Nguyen D. et al, (2020), Journal of Hepatology, 73, 794 - 799
Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
Journal article
Maponga TG. et al, (2020), Journal of Infection, 81, 121 - 130
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure
Journal article
Smith DA. et al, (2020)
Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir
Journal article
Wing PAC. et al, (2019), Gastroenterology, 157, 692 - 704.e9
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
Journal article
Downs LO. et al, (2019), mBio, 10
Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
Journal article
Smith D. et al, (2019), Hepatology, 69, 1861 - 1872
Interpreting Viral Deep Sequencing Data with GLUE
Journal article
Singer J. et al, (2019), Viruses, 11, 323 - 323
Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse
Journal article
Bonsall D. et al, (2018), Infection and Drug Resistance, Volume 11, 1119 - 1135